Back to School: How biopharma can reboot drug development. Access exclusive analysis here
HGSI began an open-label Phase II trial to evaluate carboplatin and paclitaxel with or without
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury